Abstract P1-11-09: Five Year Follow Up of a Randomized Phase II Comparison of Neo-Adjuvant Docetaxel, Carboplatin, Trastuzumab with or Without Lapatinib in HER-2 Positive Breast Cancer
Cancer Research(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined